Taiwan's Biannual Price Cuts Has Companies Seeing Red
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Taiwan's government plans to carry forward with a biannual round of cuts to drug prices despite intense opposition from the pharmaceutical industry